Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 91Leukemia, Myeloid, Acute 77Precursor Cell Lymphoblastic Leukemia-Lymphoma 63Leukemia 49Lymphoma, Non-Hodgkin 45Lymphoma 41Leukemia, Lymphocytic, Chronic, B-Cell 41Hodgkin Disease 39Myeloproliferative Disorders 32Multiple Myeloma 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Leukemia, Myelomonocytic, Chronic 23Leukemia, Myeloid, Accelerated Phase 23Leukemia, Myeloid, Chronic-Phase 22Burkitt Lymphoma 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Congenital Abnormalities 21Lymphoma, Follicular 20Primary Myelofibrosis 19Lymphoma, Large B-Cell, Diffuse 19Neoplasms, Plasma Cell 18Lymphoma, Large-Cell, Immunoblastic 18Graft vs Host Disease 18Myelodysplastic-Myeloproliferative Diseases 17Blast Crisis 17Anemia, Refractory, with Excess of Blasts 17Dendritic Cell Sarcoma, Interdigitating 15Leukemia, Myelomonocytic, Juvenile 14Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 14

Interventions

Radiotherapy 1Methylprednisolone 1Melphalan 1Imatinib Mesylate 1Fentanyl 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Busulfan 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymoma × Melphalan × Myeloid × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡